On Tuesday, Staar Surgical Co (NASDAQ: STAA) opened higher 3.31% from the last session, before settling in for the closing price of $24.17. Price fluctuations for STAA have ranged from $23.72 to $52.68 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 21.55% over the past five years. Company’s average yearly earnings per share was noted -29.11% at the time writing. With a float of $48.96 million, this company’s outstanding shares have now reached $49.27 million.
Let’s look at the performance matrix of the company that is accounted for 1115 employees. In terms of profitability, gross margin is 78.73%, operating margin of 7.53%, and the pretax margin is 10.26%.
Staar Surgical Co (STAA) Insider Updates
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Staar Surgical Co is 0.65%, while institutional ownership is 98.25%. The most recent insider transaction that took place on Dec 16 ’24, was worth 1,297,084. In this transaction 10% Owner of this company bought 53,500 shares at a rate of $24.24, taking the stock ownership to the 10,821,931 shares. Before that another transaction happened on Dec 18 ’24, when Company’s 10% Owner bought 23,000 for $24.33, making the entire transaction worth $559,493. This insider now owns 10,848,631 shares in total.
Staar Surgical Co (STAA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -29.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to 31.51% growth over the previous five years of trading.
Staar Surgical Co (NASDAQ: STAA) Trading Performance Indicators
Check out the current performance indicators for Staar Surgical Co (STAA). In the past quarter, the stock posted a quick ratio of 5.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.61. Likewise, its price to free cash flow for the trailing twelve months is 46.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.44, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.85 in one year’s time.
Technical Analysis of Staar Surgical Co (STAA)
Staar Surgical Co (NASDAQ: STAA) saw its 5-day average volume 0.68 million, a negative change from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 32.55%. Additionally, its Average True Range was 1.37.
During the past 100 days, Staar Surgical Co’s (STAA) raw stochastic average was set at 7.23%, which indicates a significant decrease from 30.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.64% in the past 14 days, which was lower than the 55.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.93, while its 200-day Moving Average is $36.86. Nevertheless, the first resistance level for the watch stands at $25.35 in the near term. At $25.72, the stock is likely to face the second major resistance level. The third major resistance level sits at $26.41. If the price goes on to break the first support level at $24.29, it is likely to go to the next support level at $23.60. Assuming the price breaks the second support level, the third support level stands at $23.23.
Staar Surgical Co (NASDAQ: STAA) Key Stats
There are currently 49,276K shares outstanding in the company with a market cap of 1.23 billion. Presently, the company’s annual sales total 322,420 K according to its annual income of 21,350 K. Last quarter, the company’s sales amounted to 88,590 K and its income totaled 9,980 K.
